Project Number AFTD-Haass-2017 Agency/Funding Organization The Association for Frontotemporal Degeneration Funding Year 2017 View Full Project Details for sTREM2, PGRN, and GRN as CSF markers for microglial activity, disease progression, and therapeutic target engagement Research Categorization Primary Disease / Condition Frontotemporal Dementia CADRO Category B. Diagnosis, Assessment, and Disease Monitoring 1. Fluid Biomarkers a. CSF Biomarkers Researcher and Organization Principal Investigator Haass, Christian Principal Investigator First Name Christian Principal Investigator Last Name Haass Awardee Organization Ludwig Maximilian University of Munich Contact PI Country Germany Project Detail Funding Opportunity Announcement FTD Biomarkers Initiative RFP FY Overall Cost $450,000 Funding Organization Agency/Funding Organization The Association for Frontotemporal Degeneration Funding Organization Country United States Program Official Debra Niehoff Special Initiative FTD Biomarkers Initiative
